Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Efficacy And Safety Of TUDCA Compare UDCA In The Treatment Of Cholestatic Liver Disease-PBC by A Randomized,Double-Blind,Double Dummy,Parallel-Controlled,Multicenter Trial and The Consecutive Treatment By TUDCA

NCT01829698 is registered in ClinicalTrials.gov with Beijing Trendful Kangjian Medical Information Consulting Limited Company as lead sponsor.

NCT NCT01829698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Efficacy And Safety Of TUDCA Compare UDCA In The Treatment Of Cholestatic Liver Disease-PBC by A Randomized,Double-Blind,Double Dummy,Parallel-Controlled,Multicenter Trial and The Consecutive Treatment By TUDCA
Lead sponsor
Beijing Trendful Kangjian Medical Information Consulting Limited Company
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2009
Completion date
February 28, 2014
Enrollment
199 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholestatic liver disease